Participants 77 132 4
anemic critically ill patients without acute blood loss
Participants 135 387 5
OBJECTIVE To describe the pharmacokinetic profiles of six different dosing regimens for epoetin alfa, and whether more rapid and robust reticulocytosis can be elicited with more frequent administration of epoetin alfa in anemic critically ill patients.
Participants 463 496 5
Ten centers in the United States.
Participants 497 656 7
PATIENTS Adult (age >or=18 years) critically ill patients with hemoglobin <or=12 g/dL, expected hospitalization of >or=7 days, with no ongoing acute blood loss
